Mitomycin induced pulmonary veno-occlusive disease

Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxicity as well as PVOD adverse effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunadu, Afua, Stalls, J. Stephen, Labuschagne, Heloise, Thayyil, Abdullah, Falls, Randall, Maddipati, Veeranna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348923/
https://www.ncbi.nlm.nih.gov/pubmed/34401312
http://dx.doi.org/10.1016/j.rmcr.2021.101437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348923/
https://www.ncbi.nlm.nih.gov/pubmed/34401312
http://dx.doi.org/10.1016/j.rmcr.2021.101437

Ejemplares similares